Monopar Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Monopar Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monopar Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monopar Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $33k | 45k | 0.73 |
| 2024-03-31 | $31k | 45k | 0.68 |
| 2023-12-31 | $15k | 45k | 0.34 |
| 2023-09-30 | $54k | 88k | 0.62 |
| 2023-06-30 | $85k | 99k | 0.86 |
| 2023-03-31 | $139k | 100k | 1.39 |
| 2022-12-31 | $237k | 100k | 2.37 |
| 2022-06-30 | $230k | 100k | 2.30 |
| 2022-03-31 | $255k | 100k | 2.55 |
| 2021-09-30 | $487k | 100k | 4.87 |
| 2021-06-30 | $574k | 98k | 5.89 |
| 2021-03-31 | $279k | 45k | 6.19 |
Top funds holding Monopar Therapeutics
View all funds holding Monopar Therapeutics